Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BRKR | Common Stock | Options Exercise | $164K | +10K | +16.69% | $16.42* | 69.9K | Dec 6, 2022 | Direct | |
transaction | BRKR | Common Stock | Options Exercise | $191K | +10K | +14.3% | $19.07 | 79.9K | Dec 6, 2022 | Direct | |
transaction | BRKR | Common Stock | Sale | -$1.32M | -20K | -25.03% | $66.18 | 59.9K | Dec 6, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BRKR | Stock Option (Right to Buy) | Options Exercise | $0 | -10K | -100% | $0.00* | 0 | Dec 6, 2022 | Common Stock | 10K | $16.42 | Direct | F2 |
transaction | BRKR | Stock Option (Right to Buy) | Options Exercise | $0 | -10K | -100% | $0.00* | 0 | Dec 6, 2022 | Common Stock | 10K | $19.07 | Direct | F3 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.78 to $66.52, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F2 | The stock option granted to the Reporting Person on January 7, 2013 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |
F3 | The stock option granted to the Reporting Person on January 6, 2014 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |